A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SPMs / second primary malignancies

[Related PubMed/MEDLINE]
Total Number of Papers: 57
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SPMs  (>> Co-occurring Abbreviation)
Long Form:   second primary malignancies
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States. APC, EARs, PYR, SIRs
2018 Clinical and Prognostic Analysis of Hypopharyngeal Squamous Cell Carcinoma with Synchronous and Metachronous Multiple Malignancies. HSCC
2018 Impact of latency time on survival for adolescents and young adults with a second primary malignancy. CI, CSS, HR, PM
2018 Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents. MM
2018 Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy. FG, HNSCC, HPV, PH
2018 Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study. AERs, CI, SEER, SIRs
2018 Second primary malignancies after high-dose-rate 60Co photon or 252Cf neutron brachytherapy in conjunction with external-beam radiotherapy for endometrial cancer. HDR, RT
2018 The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study. O/E, SEER-13
2017 Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer. HPV, SCCA, SIRs
10  2017 Pattern of occurrence and treatment outcome of second primary malignancies: A single center experience. ---
11  2017 Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study. CI, PCa, RT, SHRs
12  2017 Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments. CI, SIRs, TKIs
13  2017 Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study. FL, SIR
14  2017 Second primary malignancies in multiple myeloma: an overview and IMWG consensus. MM
15  2016 Canadian cost analysis comparing maintenance therapy with bortezomib versus lenalidomide for patients with multiple myeloma post autologous stem cell transplant. AEs, ASCT, MM
16  2016 Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. BR, FC, HR, RTs
17  2016 Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer. RR
18  2016 Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program. AEs, EAP, OS, PFS, RRMM, SFDA, TTP
19  2016 Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. HNSCC, OS, SEER
20  2016 Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma. auto-HCT, CI, HR, MM, OS, PFS
21  2016 Second primary malignancies among patients with myeloma-related-diseases in the KMF database. KMF
22  2016 Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan. HR, SIRs
23  2015 Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma. MM
24  2015 Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan. COPD, CRC, SIRs
25  2015 Increased risk of second primary malignancies following uterine cancer: a population-based study in Taiwan over a 30-year period. SIRs
26  2015 Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood. HL
27  2015 Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer. BT, HDR, PY
28  2015 The association between breast cancer and thyroid cancer: a meta-analysis. CI
29  2015 The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study. CC, CRC, RC, SEER, SIRs
30  2015 The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies. GIST
31  2015 Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies. SCC
32  2015 [Second primary malignancies after the treatment of multiple myeloma]. ---
33  2014 Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients. HNSCC, PCR, SPM
34  2014 Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. ACR, CI, CMM, NMSC
35  2014 Second primary malignancies in patients with neuroendocrine tumors. NETs
36  2014 Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups. MM
37  2013 BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma. MM
38  2013 Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. HPV
39  2013 Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. HNSCC
40  2013 Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma. ASCT, MM, NMSCs
41  2013 Second primary malignancies following thyroid cancer: a population-based study in Taiwan. SIRs
42  2013 Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. HNSCC, HPV, SIR
43  2013 Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: A case report and review of the literature. NEBC, NETs, WHO
44  2013 The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. HNC, NPC
45  2013 [Seminona of stage I: strategies compared]. MRC
46  2012 A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide. CI, MM
47  2012 Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma. EBRT
48  2012 Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. HNC
49  2012 Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. TT2, TT3
50  2011 Distinct features of second primary malignancies in head and neck cancer patients in Japan. ---
51  2009 Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. ---
52  2009 Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. CI, RAI, RR
53  2007 Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. SIRs
54  2007 Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. HNSCC, NPC
55  2003 Second primary malignancies in thyroid cancer patients. ---
56  1992 Second primary malignancies following diagnosis of small-cell lung cancer. HM, MSPMs, NSCLC, OST, SCLC, SSPMs
57  1987 Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multicentre study. ---